Financial results - VALI-PHARM SRL

Financial Summary - Vali-Pharm Srl
Unique identification code: 15916961
Registration number: J24/1298/2003
Nace: 4773
Sales - Ron
275.055
Net Profit - Ron
11.803
Employees
2
Open Account
Company Vali-Pharm Srl with Fiscal Code 15916961 recorded a turnover of 2024 of 275.055, with a net profit of 11.803 and having an average number of employees of 2. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Vali-Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 188.303 183.287 165.817 145.388 157.752 194.209 189.864 210.731 221.956 275.055
Total Income - EUR 188.306 184.444 166.198 150.453 157.752 194.209 190.034 210.731 221.956 275.055
Total Expenses - EUR 175.552 181.907 162.849 148.320 152.225 176.578 177.470 198.263 212.889 261.125
Gross Profit/Loss - EUR 12.754 2.537 3.348 2.133 5.526 17.631 12.564 12.468 9.067 13.930
Net Profit/Loss - EUR 10.140 1.199 1.633 624 3.940 15.983 10.656 10.461 7.111 11.803
Employees 4 4 2 2 2 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 24.6%, from 221.956 euro in the year 2023, to 275.055 euro in 2024. The Net Profit increased by 4.732 euro, from 7.111 euro in 2023, to 11.803 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Vali-Pharm Srl

Rating financiar

Financial Rating -
VALI-PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Vali-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Vali-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Vali-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Vali-Pharm Srl - CUI 15916961

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 39.259 44.104 59.159 54.194 50.628 51.248 54.150 53.411 47.731 50.707
Current Assets 93.036 75.573 80.016 92.701 98.842 101.081 114.148 109.532 125.305 132.150
Inventories 53.254 44.231 48.403 53.731 71.531 72.798 65.749 69.084 76.382 95.505
Receivables 25.197 10.688 26.995 38.589 23.825 15.196 30.666 35.096 47.664 35.479
Cash 14.585 20.654 4.618 381 3.486 13.088 17.733 5.351 1.259 1.166
Shareholders Funds 76.729 77.146 76.652 75.869 78.340 92.837 101.434 90.919 97.754 109.012
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 55.566 42.531 62.523 71.025 71.131 59.493 66.864 72.024 75.282 73.846
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 132.150 euro in 2024 which includes Inventories of 95.505 euro, Receivables of 35.479 euro and cash availability of 1.166 euro.
The company's Equity was valued at 109.012 euro, while total Liabilities amounted to 73.846 euro. Equity increased by 11.803 euro, from 97.754 euro in 2023, to 109.012 in 2024.

Risk Reports Prices

Reviews - Vali-Pharm Srl

Comments - Vali-Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.